In this study, we employed breast cancer cells expressing commonly observed ESR1 mutations (Y537N and Y537S) and wt ER counterparts and evaluated their growth in the presence/absence of estrogen (E2; Fig. 1). The gene discussed is ESR1; the disease is breast carcinoma.